Mechanism of Xuebijing Injection in anti-acute lung injury based on network pharmacology
10.7501/j.issn.0253-2670.2018.15.011
- Author:
Li-Hua ZUO
1
Author Information
1. Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University
- Publication Type:Journal Article
- Keywords:
Acute lung injury;
Akt;
Mitogen-activated protein kinase;
Network pharmacology;
Phosphatidyl inositol 3-kinase;
Reverse molecular docking;
Xuebijing Injection
- From:
Chinese Traditional and Herbal Drugs
2018;49(15):3541-3549
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To predict the action targets of anti-acute lung injury active ingredients of Xuebijing Injection, and investigate the “multi-components, multi-targets, and multi-pathways” mechanism. Methods: Reverse molecular docking was used to forecast its targets of 38 main active components of Xuebijing Injection. The relevant targets of acute lung injury were searched through literature mining and multiple databases and compared with the predicted component targets. The protein interaction network was constructed by Cytoscape software, and topological analysis was performed to screen the key targets of anti-acute lung injury of Xuebijing Injection. And GO enrichment analysis and KEGG analysis were carried out on the key targets through DAVID database. Results: The network analysis indicated that 38 active ingredients affected 143 key target proteins directly or indirectly, involved in 71 biological processes, 29 cellular components, 40 molecular function, and 25 KEGG pathways. These active compounds might participate in regulating the processes of gene, protein, external stimulus, and interfering the mitogen-activated protein kinase (MAPK), phosphatidyl inositol 3-kinase (PI3K)-Akt, and other signaling pathways to play a role in resisting to acute lung injury. Conclusion: The anti-acute lung injury effect of Xuebijing Injection showed the characteristics of traditional Chinese medicine in multi-components, multi-targets, and multi-pathways. This research provides a scientific basis for elucidation of the anti-acute lung injury pharmacological mechanism of Xuebijing Injection.
